SAPHNELO (anifrolumab-fnia) Access & Reimbursement Guide
November 20, 2023
The AstraZeneca Access 360™ program provides personal support to connect patients to affordability programs and streamline access and reimbursement for SAPHNELO.
For more information on Physician Office Coding, CMS-1500 Claim Form, Hospital Outpatient Department Coding, UB-04 Claim Form, Prior Authorizations, and Appeals, click here!
For US Healthcare Professionals
SAPHNELO is a registered trademark and AstraZeneca Access 360 is a trademark of the AstraZeneca group of companies.
©2023 AstraZeneca. All rights reserved. US-81251 Last Updated 11/23